India's benchmark Nifty 50 index is set to open marginally higher on Thursday after sinking into correction territory in the ...

Mumbai: Cipla has announced that the United States Food and Drugs Administration (USFDA) has concluded an inspection at the ...

Cipla Ltd. announced on Wednesday that the company received eight observations from the US Food and Drug Administration for ...

Stay informed with the Cipla Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of a ...

An analyst from YES Securities said that Lupin has broken down from a descending triangle pattern on daily timeframe, ...

The development reflects the company's strategy to raise funds and expand its market position. CIPLA Cipla is in focus due to ...

Cipla , India's third-largest generic drugmaker by sales, reported a 15.2% rise in second-quarter profit that beat estimates, ...

Following an inspection of its Bengaluru facility, Cipla has received 8 observations in Form 483 from the US Food and Drug ...

Cipla's shares are in focus as the company reported a 15% YoY increase in consolidated net profit to Rs 1,303 crore for Q2 ...

Cipla Ltd, a major player in the Indian pharmaceutical sector, currently trades at ₹1,418. This price reflects a decrease of ...

Total research and development spend reached Rs 385 crore, equivalent to 5.5 per cent of sales, a 2 per cent increase Y-o-Y.

The US Food and Drugs Administration (USFDA) conducted an inspection at the company's manufacturing facility in Virgonagar, ...